This website uses cookies to enhance the user experience.
B

BIOVOTEC AS913 037 790

Research
Limited company
Haakon VIIs gate 5 0161 OSLO, Norge

BIOVOTEC AS

BIOVOTEC - Innovative Solutions in Wound Healing : New Biomaterial...
Biovotec is engaged in transforming future wound healing, skin applications using innovation inspired by nature and wound care products...

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Links

Organization

Chairman of the board
Years since formation
10 years
since Jan 7, 2014
Type
Limited company
VAT registered
Yes
Number of employees
0

Ownership

Number of shares and share classes
1,235,573
1 share class
Total number of shareholders
151
46 companies, 105 persons

Financials

Total operating income 2023
1,447,808
NOK
Annual total result 2023
-16,391,933
NOK
Total equity 2023
22,788,845
NOK
Last update: Nov 21, 2024

Management

Board

NameRoleShares
Chairman-
Board Member
4.83 %
indirectly
Board Member
4.46 %
indirectly

Others

NameRoleShares
R
RSM NORGE AS
Auditor-

Top 10 individual shareholders

NameRoleShares
-
14.41 %
directly
-
6.34 %
directly 0.36 %
indirectly 5.98 %
-
5.67 %
indirectly
Board Member
4.83 %
indirectly
-
4.65 %
indirectly
Board Member
4.46 %
indirectly
-
2.81 %
directly
-
2.71 %
directly 0.29 %
indirectly 2.42 %
-
2.51 %
indirectly
-
2.42 %
indirectly
Last update: Sep 9, 2024

Ownership

Company shareholders

NameShare classNumber of sharesShare
NO0010789415
178,034
14.41 %
A
ALYLA AS
NO0010789415
149,335
12.09 %
B
BIOVOTEC AS
NO0010789415
112,971
9.14 %
T
TJELD AS
NO0010789415
85,605
6.93 %
F
FIRST PARTNERS HOLDING 8 AS
NO0010789415
73,880
5.98 %
B
BENARES AS
NO0010789415
71,887
5.82 %
H
HURD AS
NO0010789415
70,000
5.67 %
M
MIRAX AS
NO0010789415
55,049
4.46 %
NO0010789415
34,667
2.81 %
S
SKALTOR AS
NO0010789415
30,380
2.46 %
S
SARAFINA AS
NO0010789415
21,852
1.77 %
M
MAHA NORGE AS
NO0010789415
20,224
1.64 %
V
VALTOR AS
NO0010789415
16,087
1.3 %
S
STOKNES FUTURES AS
NO0010789415
15,868
1.28 %
V
VATLESTRAUMEN INVEST AS
NO0010789415
15,033
1.22 %
NO0010789415
14,809
1.2 %
MM
NO0010789415
14,701
1.19 %
G
GLENNE INVEST AS
NO0010789415
13,168
1.07 %
A
AKROBAT INVEST AS
NO0010789415
12,200
0.99 %
NO0010789415
11,804
0.96 %
NO0010789415
11,458
0.93 %
D
DMS INVEST AS
NO0010789415
11,365
0.92 %
L
LANGEFINNE AS
NO0010789415
10,944
0.89 %
NO0010789415
10,454
0.85 %
U
UTGARD AS
NO0010789415
10,392
0.84 %
T
THEMAR EIENDOM AS
NO0010789415
6,888
0.56 %
NO0010789415
6,147
0.5 %
H
HUITFELDT-KAAS AS
NO0010789415
5,715
0.46 %
M
MUTLE AS
NO0010789415
5,609
0.45 %
NO0010789415
5,329
0.43 %
NO0010789415
5,098
0.41 %
NO0010789415
4,619
0.37 %
NO0010789415
4,458
0.36 %
NO0010789415
4,430
0.36 %
NO0010789415
4,171
0.34 %
NO0010789415
4,103
0.33 %
M
MONITA AS
NO0010789415
4,034
0.33 %
F
FIRIOL INVEST AS
NO0010789415
3,814
0.31 %
NO0010789415
3,790
0.31 %
NO0010789415
3,619
0.29 %
NO0010789415
3,354
0.27 %
O
OVE LERDAHL AS
NO0010789415
3,324
0.27 %
S
SKREDE INVEST AS
NO0010789415
3,300
0.27 %
L
LYNG EIENDOM HOLDING AS
NO0010789415
3,185
0.26 %
NO0010789415
2,959
0.24 %
NO0010789415
2,899
0.23 %
NO0010789415
2,814
0.23 %
NO0010789415
2,788
0.23 %
S
SMÅSTØLANE AS
NO0010789415
2,711
0.22 %
NO0010789415
2,329
0.19 %
F
FJORD-PARTNERS AS
NO0010789415
2,258
0.18 %
NO0010789415
2,212
0.18 %
NO0010789415
2,192
0.18 %
NO0010789415
2,142
0.17 %
NO0010789415
2,078
0.17 %
NO0010789415
2,000
0.16 %
M
MAFELA AS
NO0010789415
1,760
0.14 %
NO0010789415
1,717
0.14 %
NO0010789415
1,592
0.13 %
NO0010789415
1,558
0.13 %
T
NO0010789415
1,519
0.12 %
H
HYDLE EIGEDOM AS
NO0010789415
1,497
0.12 %
NO0010789415
1,467
0.12 %
NO0010789415
1,464
0.12 %
NO0010789415
1,331
0.11 %
NO0010789415
1,274
0.1 %
A
AMUNDSEN & SELJORD AS
NO0010789415
1,267
0.1 %
M
MOLDBAKKEN AS
NO0010789415
1,122
0.09 %
NO0010789415
1,056
0.09 %
B
BIOMAR CONSULTING AS
NO0010789415
1,010
0.08 %
NO0010789415
1,000
0.08 %
NO0010789415
1,000
0.08 %
NO0010789415
900
0.07 %
G
GRÜNDERSEN AS
NO0010789415
888
0.07 %
NO0010789415
885
0.07 %
NO0010789415
864
0.07 %
NO0010789415
850
0.07 %
NO0010789415
832
0.07 %
O
OTTO HOLMEN AS
NO0010789415
777
0.06 %
NO0010789415
740
0.06 %
NO0010789415
700
0.06 %
NO0010789415
700
0.06 %
NO0010789415
700
0.06 %
NO0010789415
700
0.06 %
S
SCAN-AMERICAN TRADING CO AS
NO0010789415
699
0.06 %
NO0010789415
641
0.05 %
NO0010789415
632
0.05 %
NO0010789415
622
0.05 %
R
ROAS AS
NO0010789415
600
0.05 %
NO0010789415
583
0.05 %
NO0010789415
583
0.05 %
NO0010789415
560
0.05 %
NO0010789415
518
0.04 %
NO0010789415
494
0.04 %
E
ENBRAS AS
NO0010789415
467
0.04 %
NO0010789415
467
0.04 %
NO0010789415
467
0.04 %
NO0010789415
432
0.03 %
NO0010789415
432
0.03 %
NO0010789415
419
0.03 %

Shares owned by the BIOVOTEC AS

NameShare classNumber of sharesShare
B
BIOVOTEC AS
NO0010789415
112,971
9.14 %
Last update: May 24, 2024

Financials

in NOK

Summary

Year202320222021
Total operating income
1,447,808
9,025,999
2,006,097
Annual Total Result
-16,391,933
-149,613
-11,352,986
Total assets
26,068,053
20,565,125
34,464,705
Total liabilities
3,279,208
1,617,948
15,367,915
Total equity
22,788,845
18,947,178
19,096,790

P&L

Year202320222021
Total operating income
1,447,808
9,025,999
2,006,097
Total operating costs
18,705,437
9,595,015
12,754,348
Operating result
-17,257,629
-569,017
-10,748,251
Financial income/costs
865,696
419,404
-604,734
Profit before tax
-16,391,933
-149,613
-11,352,986
Total tax & extraordinary income/cost
0
0
0
Annual Total Result
-16,391,933
-149,613
-11,352,986

Balance overview

Year202320222021
Total fixed assets
1,726,254
1,574,894
2,200,398
Total current assets
24,341,799
18,990,231
32,264,307
Total assets
26,068,053
20,565,125
34,464,705
Short term debt
3,279,208
1,617,948
15,367,915
Long term debt
0
0
0
Total liabilities
3,279,208
1,617,948
15,367,915
Contributed capital
22,788,845
18,947,178
19,096,790
Retained earnings
0
0
0
Total equity
22,788,845
18,947,178
19,096,790
Total equity and liabilities
26,068,053
20,565,125
34,464,705

Classification

Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.11
Industrial group
Research and experimental development on biotechnology
72.110
Industrial group
Research and experimental development on biotechnology